Peptide Therapeutics Market Growth and Trends 2020

1
Your Catalyst To a Lucrative Business Peptide
Therapeutics Market Share, Size, Analysis,
Growth, Trends and Forecasts to 2020 Hexa
Research
" Peptide therapeutics market is expected to
grow over the forecast period owing to the
increasing prevalence of cancer and other
various metabolic diseases."
Rising cases of cancer and high incidence of a
number of metabolic diseases propel the global
Peptide Therapeutics Market. Other industry
drivers are prevalence of lifestyle diseases,
introduction of hybrid methods of peptides
synthesis, growing global population, and
improved healthcare infrastructure. A molecule
containing two or more amino acids is known as a
peptide. Therapeutic peptides are short amino
acid monomer chains. Peptides are commonly known
as amide bonds. These are used to treat
blood-based disorders, certain types of cancers,
chronic ailments, CNS (central nervous system)
disorders, and cardiovascular respiratory
anomalies. Growing importance of peptide
therapeutics in the pharmaceutical market may
significantly contribute to overall demand during
the forecast period (2012 to 2020). However,
changing customer needs and lack of regulatory
standards hinder industry progress. Browse
Details of Report _at_ https//www.hexaresearch.com/
research -report/peptide-therapeutics- industry
2
Your Catalyst To a Lucrative Business The
worldwide peptide therapeutics market is
categorized on the basis of technologies,
applications, routes of administration, products,
and regions. Based on technologies, the segments
are HPPS (hybrid phase peptide synthesis), LPPS
(liquid phase peptide synthesis), and SPPS (solid
phase peptide synthesis). Owing to cost
effectiveness and user-friendliness, SPPS was the
largest contributor to the overall industry in
2013.On the basis of applications, the market is
divided into respiratory, cancer, anti-infection,
pain, metabolic, cardiovascular, dermatology,
renal, gastro intestinal, and others. In 2013,
peptide therapeutics were used extensively in
cancer treatment. High incidence of cancer cases
worldwide is expected to fuel this segment till
2020. According to routes of administration, the
industry is segmented into mucosal, pulmonary,
parenteral, oral, aYd others. ?Others? iYÐludes
Yasal aYd iYtraderwal. PareYteral held the
highest industry share in 2013. Based on
products, the bifurcations are generic and
innovative. Innovative peptides dominated the
overall industry in 2013. As per regions, the
global peptide therapeutics market is categorized
into Europe, Asia Pacific, Nor th America, and
Rest of the World. North America leads the global
industry because of high per capita expenditure
on healthcare, rising income levels, and
improvements in healthcare infrastructure. The
region receives substantial support from the
government and also from a number of NGOs. Asia
Pacific may witness robust growth over the
forecast period because of economic progress,
favorable government initiatives, and growing
population. Japan, China, and India are the three
key regional drivers of the Asia Pacific market.
Prominent companies operating in the global
peptide therapeutics market are Eli Lilly and
Company Takeda Pharmaceutical Company Ltd.
Amylin Pharmaceuticals LLC Bachem Holding AG
and Teva Pharmaceuticals. Rhythm, a U.S. based
biopharmaceutical company dealing in peptide
therapeutics presented the phase 2 ÐliYiÐal trial
assessweYt of setwelaYotide iY Noewder ???6.
SetwelaYotide, a peptide drug, is the ÐowpaYys
melanocortin-4 receptor agonist that is generally
used to treat LepR (leptin receptor) deficiency
obesity. This is a rare genetic anomaly that
leads to unrelenting hyperphagia and severe
obesity. According to the company, this disorder
affects nearly two thousand people in the U.S. on
an annual basis. Caused by deficiencies defects
in the MC4 pathway, LepR deficiency obesity
affects people in their early childhood. The MC4
pathway in humans regulates appetite, energy
expenditure, and homeostasis. SetwelaYotides
effiÐaÐy ?as tested dy researÐhers ?heY it ?as
adwiYistered eeryday by subcutaneous injection.
Over a period of 22 weeks, a LepR patient lost
weight by almost 20. Browse Related Category
Market Reports _at_ https//www.hexaresearch.com/rese
arch-category/healthcare-it- industry
3

• Your Catalyst To a Lucrative Business
• Table of Content of Peptide Therapeutics Market
• Chapter 1 Executive Summary
• 1.1 Peptide Therapeutics Industry Summary
  Critical Success Factors (CSFs)
• Chapter 2 Peptide Therapeutics Industry Outlook
• Market Segmentation
• Market Size and Growth Prospects
• Peptide Therapeutics Value Chain Analysis
• Peptide Therapeutics Market Dynamics
• Market driver analysis
• Increase in cancer patients
• Increase in metabolic disorders
• Growth in RD
• Technological advancement
• Market restraint analysis
• Increasing complexity
• Lack of regulatory standards

4

• Your Catalyst To a Lucrative Business
• 4.2.1 Peptide Therapeutics demand from
  metabolicapplications, 2012-2020 (USD Million)
• 4.3 Cardiovascular
• 4.3.1 Peptide Therapeutics demand from
  cardiovascularapplications, 2012 -2020 (USD
  Million)
• 4.4 Dermatology
• 4.4.1 Peptide Therapeutics demand from
  Dermatologyapplications, 2012-2020 (USD Million)
• 4.5 Anti-infection
• 4.5.1 Peptide Therapeutics demand from
  anti-infection applications, 2012-2020 (USD
  Million)
• 4.6 Gastro Intestinal
• 4.6.1 Peptide Therapeutics demand from gastro
  intestinal applications, 2012 -2020 (USD Million)
  4.7Renal
• 4.7.1 Peptide Therapeutics demand from renal
  applications, 2012-2020 (USD Million)
• 4.8 Respiratory
• 4.8.1 Peptide Therapeutics demand from
  respiratory applications, 2012 -2020 (USD
  Million)
• 4.9 Pain
• 4.9.1 Peptide Therapeutics demand from pain
  applications, 2012-2020 (USD Million)
• 4.10 Others
• 4.10.1 Peptide Therapeutics demand from other
  applications, 2012-2020 (USD Million)
• Chapter 5 Peptide Therapeutics Route Outlook

5

• Your Catalyst To a Lucrative Business
• Chapter 7 Peptide Therapeutics Regional Outlook
• North America
• Peptide Therapeutics market volume revenue by
  technology, 2012-2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  application, 2012 -2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  route, 2012-2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  product, 2012-2020 (USD Million)
• Europe
• Peptide Therapeutics market volume revenue by
  technology, 2012 -2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  application, 2012 -2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  route, 2012-2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  product, 2012-2020 (USD Million)
• Asia Pacific
• Peptide Therapeutics market volume revenue by
  technology, 2012 -2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  application, 2012 -2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  route, 2012-2020 (USD Million)
• Peptide Therapeutics market volume revenue by
  product, 2012-2020 (USD Million)
• RoW
• Peptide Therapeutics market volume revenue by
  technology, 2012 - 2020 (USD Million)

6

• Your Catalyst To a Lucrative Business
• Product Benchmarking
• Strategic Initiatives
• Bachem Holding AG
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Eli Lilly and Company
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• GlaxoSmithKline (GSK)
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Ipsen

7

• Your Catalyst To a Lucrative Business
• 8.10.4. Strategic Initiatives
• Novo- Nordisk A/S
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Peptisyntha
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• PolyPeptide Group.
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Pfizer Inc.
• Company Overview

8

• Your Catalyst To a Lucrative Business
• Teva Pharmaceuticals
• Company Overview
• Financial Performance
• Product Benchmarking
• Strategic Initiatives
• Chapter 9 Methodology Scope
• Research Methodology
• Research Scope Assumptions
• List of Data Sources

9
Your Catalyst To a Lucrative Business About
Us Hexa Research is a market research and
consulting organization, offering industry
reports, custom research and consulting services
to a host of key industries across the globe. We
offer comprehensive business intelligence in the
form of industry reports which help our clients
obtain clarity about their business environment
and enable them to undertake strategic growth
initiatives. Contact Us Ryan Shaw Hexa
Research Felton Office Plaza 6265 Highway
9 Felton, California 95018 United States Phone
1-800-489-3075 Email sales_at_hexaresearch.com Webs
ite - http//www.hexaresearch.com/